• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.

作者信息

Greenwood Mandy, Shipa Muhammad, Yeoh Su-Ann, Roussou Euthalia, Mukerjee Dev, Ehrenstein Michael R

机构信息

Centre for Rheumatology, UCL, London, UK.

Rheumatology Department, Barking Havering and Redbridge University Hospitals NHS Trust, Romford, Essex, UK.

出版信息

Ann Rheum Dis. 2020 Nov;79(11):1516-1517. doi: 10.1136/annrheumdis-2020-217725. Epub 2020 May 28.

DOI:10.1136/annrheumdis-2020-217725
PMID:32467248
Abstract
摘要

相似文献

1
Methotrexate reduces withdrawal rates of TNF inhibitors due to ineffectiveness in rheumatoid arthritis but only in patients who are seropositive.甲氨蝶呤可降低类风湿关节炎患者中因肿瘤坏死因子抑制剂无效而导致的停药率，但仅在血清学阳性患者中有效。
Ann Rheum Dis. 2020 Nov;79(11):1516-1517. doi: 10.1136/annrheumdis-2020-217725. Epub 2020 May 28.
2
Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.类风湿关节炎中因疗效不佳导致肿瘤坏死因子抑制剂停药与血清阳性的相关性。
Clin Rheumatol. 2019 Oct;38(10):2757-2763. doi: 10.1007/s10067-019-04626-x. Epub 2019 Jun 10.
3
Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.肿瘤坏死因子（TNF）阻断剂与类风湿关节炎和银屑病患者患阿尔茨海默病的风险降低相关。
PLoS One. 2020 Mar 23;15(3):e0229819. doi: 10.1371/journal.pone.0229819. eCollection 2020.
4
Association of tumor necrosis factor-α inhibitors and liver cirrhosis in patients with rheumatoid arthritis: A nationwide population-based nested case-control study.肿瘤坏死因子-α 抑制剂与类风湿关节炎患者肝硬化的相关性：一项全国范围内基于人群的巢式病例对照研究。
Int J Rheum Dis. 2022 Mar;25(3):327-334. doi: 10.1111/1756-185X.14272. Epub 2022 Jan 7.
5
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study.甲氨蝶呤可延长肿瘤坏死因子抑制剂的疗效，但仅在自身抗体阳性的类风湿性关节炎中有效：一项验证性研究。
Ann Rheum Dis. 2023 Oct;82(10):e217. doi: 10.1136/annrheumdis-2020-219499. Epub 2021 Jan 13.
6
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.早期血清阴性类风湿关节炎中对常规合成 DMARDs 反应良好的预测因素：来自 ESPOIR 队列的数据。
Arthritis Res Ther. 2019 Nov 15;21(1):243. doi: 10.1186/s13075-019-2020-x.
7
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells.类风湿关节炎中活化的外周血 B 细胞及其与抗肿瘤坏死因子治疗和应答的关系：抗肿瘤坏死因子对 B 细胞影响的随机临床试验。
Arthritis Rheumatol. 2022 Feb;74(2):200-211. doi: 10.1002/art.41941. Epub 2021 Dec 27.
8
High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.类风湿关节炎患者基线时类风湿因子和抗 CCP 抗体的高滴度与循环基线 TNF 水平升高、药物水平低和临床反应降低有关：对 RISING 研究的事后分析。
Arthritis Res Ther. 2017 Sep 2;19(1):194. doi: 10.1186/s13075-017-1401-2.
9
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.依那西普一线治疗失败后阿达木单抗在类风湿关节炎和银屑病关节炎患者中的疗效和保留率：FEARLESS 队列研究。
Rheumatol Int. 2020 Feb;40(2):263-272. doi: 10.1007/s00296-019-04416-3. Epub 2019 Aug 21.
10
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.类风湿关节炎患者中，24个月抗TNF治疗与甲氨蝶呤对体重的影响：一项前瞻性观察研究
Clin Rheumatol. 2016 Jun;35(6):1615-8. doi: 10.1007/s10067-016-3244-7. Epub 2016 Apr 6.

引用本文的文献

1
Rheumatoid factors revisited in the age of biologic therapy.生物治疗时代对类风湿因子的再审视。
Rheumatology (Oxford). 2025 Mar 1;64(Supplement_2):ii15-ii24. doi: 10.1093/rheumatology/keaf035.
2
Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?首先逐渐减少传统合成改善病情抗风湿药（csDMARD）或肿瘤坏死因子抑制剂（TNFi）：抗环瓜氨酸肽抗体（ACPA）阳性或阴性类风湿关节炎发作的风险是否不同？
RMD Open. 2024 Jul 20;10(3):e004258. doi: 10.1136/rmdopen-2024-004258.
3
Differences in referral path, clinical and radiographic outcomes between seronegative and seropositive rheumatoid arthritis Mexican Mestizo patients: A cohort study.
血清阴性和血清阳性的墨西哥梅斯蒂索类风湿关节炎患者的转诊途径、临床和影像学结果的差异：一项队列研究。
PLoS One. 2024 Jun 6;19(6):e0304953. doi: 10.1371/journal.pone.0304953. eCollection 2024.
4
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis.当自身抗体缺失时：血清阴性类风湿关节炎的挑战
Antibodies (Basel). 2023 Oct 31;12(4):69. doi: 10.3390/antib12040069.
5
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis.自身抗体阴性类风湿关节炎的遗传、环境和免疫病理复杂性。
Int J Mol Sci. 2021 Nov 17;22(22):12386. doi: 10.3390/ijms222212386.
6
Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis.甲氨蝶呤降低类风湿关节炎血清学阳性患者停用肿瘤坏死因子抑制剂的概率。一项真实世界数据分析。
Front Med (Lausanne). 2021 Jun 29;8:692557. doi: 10.3389/fmed.2021.692557. eCollection 2021.